Active Ingredient(s): Sevoflurane
FDA Approved: * May 2, 2007
Pharm Company: * MINRAD
Category: Anesthetic

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Sojourn Overview

Sevoflurane is a sweet-smelling, nonflammable, highly fluorinated methyl isopropyl ether used as an inhalational anaesthetic for induction and maintenance of general anesthesia. After desflurane, it is the volatile anesthetic with the fastest onset .[1] While its offset may be faster than agents other than desflurane in a few circumstances, its offset is more often similar to that of the much older agent isoflurane. While sevoflurane is only half as soluble as isoflurane in bl...

Read more Sojourn Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Sojourn Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Liquid: 100%
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Sojourn: (1 result)

Sorted by National Drug Code
  • 66794-012 Sojourn 99.9 ml/100ml Nasal Inhalant by Piramal Critical Care Inc

Other drugs which contain Sevoflurane or a similar ingredient: (2 results)